Birdwatch Note
2023-06-25 12:42:50 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Monoclonal Antibodies were not FDA approved and according section 564 and Ivermectin was. “When certain criteria are met, including there are no adequate, approved, and available alternatives” Keyword here is “Approved” https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Written by DFC3348B1B6B7B3F316B7A8F682E7A8D606AD639B6BF17E09EC21305F7E4B716
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1672944032417296385
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1672948462759936000
- noteId - 1672948462759936000
- participantId -
- noteAuthorParticipantId - DFC3348B1B6B7B3F316B7A8F682E7A8D606AD639B6BF17E09EC21305F7E4B716 Participant Details
- createdAtMillis - 1687696970061
- tweetId - 1672944032417296385
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Monoclonal Antibodies were not FDA approved and according section 564 and Ivermectin was. “When certain criteria are met, including there are no adequate, approved, and available alternatives” Keyword here is “Approved” https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-06-25 12:42:50 UTC (1687696970061) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-26 02:09:46 UTC (1687745386207) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-06-25 16:38:42 -0500 | Rating Details | |
| 2023-06-25 16:33:17 -0500 | Rating Details | |
| 2023-06-25 16:28:38 -0500 | Rating Details | |
| 2023-06-25 16:12:22 -0500 | Rating Details | |
| 2023-06-25 15:31:28 -0500 | Rating Details | |
| 2023-06-25 14:05:06 -0500 | Rating Details | |
| 2023-06-25 13:58:39 -0500 | Rating Details | |
| 2023-06-25 13:51:39 -0500 | Rating Details | |
| 2023-06-25 13:46:22 -0500 | Rating Details | |
| 2023-06-25 13:35:11 -0500 | Rating Details | |
| 2023-06-25 13:32:53 -0500 | Rating Details | |
| 2023-06-25 13:21:06 -0500 | Rating Details | |
| 2023-06-25 13:18:23 -0500 | Rating Details | |
| 2023-06-25 12:43:28 -0500 | Rating Details | |
| 2023-06-25 12:41:00 -0500 | Rating Details | |
| 2023-06-25 12:26:01 -0500 | Rating Details | |
| 2023-06-25 12:25:19 -0500 | Rating Details | |
| 2023-06-25 11:23:00 -0500 | Rating Details | |
| 2023-06-25 11:18:45 -0500 | Rating Details | |
| 2023-06-25 11:17:31 -0500 | Rating Details | |
| 2023-06-25 10:48:27 -0500 | Rating Details | |
| 2023-06-25 10:28:43 -0500 | Rating Details | |
| 2023-06-25 10:14:01 -0500 | Rating Details | |
| 2023-06-25 10:13:00 -0500 | Rating Details | |
| 2023-06-25 10:04:52 -0500 | Rating Details | |
| 2023-06-25 09:52:09 -0500 | Rating Details | |
| 2023-06-25 09:42:25 -0500 | Rating Details | |
| 2023-06-25 09:30:59 -0500 | Rating Details | |
| 2023-06-25 09:24:08 -0500 | Rating Details | |
| 2023-06-25 09:22:55 -0500 | Rating Details | |
| 2023-06-25 09:15:13 -0500 | Rating Details | |
| 2023-06-25 09:06:08 -0500 | Rating Details | |
| 2023-06-25 08:40:56 -0500 | Rating Details | |
| 2023-06-25 08:38:04 -0500 | Rating Details | |
| 2023-06-25 08:25:32 -0500 | Rating Details | |
| 2023-06-25 08:25:21 -0500 | Rating Details | |
| 2023-06-25 08:19:49 -0500 | Rating Details | |
| 2023-06-25 08:19:03 -0500 | Rating Details | |
| 2023-06-25 08:01:09 -0500 | Rating Details | |
| 2023-06-25 07:57:55 -0500 | Rating Details | |
| 2023-06-26 13:57:06 -0500 | Rating Details | |
| 2023-06-26 01:49:37 -0500 | Rating Details | |
| 2023-06-25 22:46:46 -0500 | Rating Details | |
| 2023-06-25 22:23:49 -0500 | Rating Details | |
| 2023-06-25 21:24:47 -0500 | Rating Details | |
| 2023-06-25 21:13:21 -0500 | Rating Details |